•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A01813 Summary:

BILL NOA01813
 
SAME ASNo Same As
 
SPONSORDinowitz
 
COSPNSRRosenthal L, Hevesi, Weprin
 
MLTSPNSR
 
Add §206-c, amd §207, Pub Health L
 
Authorizes the department of health to establish a program for familial dysautonomia, Canavan's and Tay-Sachs disease screening and counseling and to provide grants and to enter into contracts with public and non-profit private entities to assist in such program; provides that participation in such program shall be voluntary and all information shall be confidential.
Go to top

A01813 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1813
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 23, 2023
                                       ___________
 
        Introduced  by  M.  of A. DINOWITZ, L. ROSENTHAL, HEVESI, WEPRIN -- read
          once and referred to the Committee on Health
 
        AN ACT to amend the public health law, in relation to the  establishment
          of  a  program  for  familial dysautonomia, Canavan's disease and Tay-
          Sachs disease screening and counseling

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new section
     2  206-c to read as follows:
     3    § 206-c. 1. Program for familial dysautonomia, Canavan's  disease  and
     4  Tay-Sachs  disease  screening  and  counseling.  The  commissioner shall
     5  establish within the department, within amounts appropriated therefor, a
     6  program for  familial  dysautonomia,  Canavan's  disease  and  Tay-Sachs
     7  disease screening and counseling for the purposes of establishing volun-
     8  tary  familial  dysautonomia,  Canavan's  disease  and Tay-Sachs disease
     9  screening and counseling  programs,  primarily  through  other  existing
    10  health programs.
    11    2.  The  commissioner may make grants to and enter into contracts with
    12  public and nonprofit private entities for the establishment  and  opera-
    13  tion  of programs under this section.  The commissioner shall promulgate
    14  regulations pursuant to this section. In making grants authorized  under
    15  this section the commissioner shall give priority to programs that:
    16    (a)    provide  services  first  to  blood relatives of known familial
    17  dysautonomia, Canavan's disease or Tay-Sachs disease victims, and second
    18  to high-risk population groups in which familial dysautonomia, Canavan's
    19  disease and Tay-Sachs disease   occur   with greatest   frequency    and
    20  especially to those persons in such groups who are entering their child-
    21  bearing years; and
    22    (b)  operate  in  areas  which the commissioner determines to have the
    23  greatest number of  persons  in  need of the  screening  and  counseling
    24  services provided under such programs.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00858-01-3

        A. 1813                             2
 
     1    3.  The  participation  by  any  individual  in any program under this
     2  section shall be wholly voluntary and shall not  be  a  prerequisite  to
     3  eligibility for, or receipt of, any other service or assistance from, or
     4  to  participation  in,  any  other  program.  All  test results, medical
     5  records  and  any  other  information  regarding  familial dysautonomia,
     6  Canavan's disease and Tay-Sachs disease screening or counseling acquired
     7  or made by a public or  private  entity  or  an  individual  under  this
     8  section  shall  be  kept  confidential  and  shall  not be admissible as
     9  evidence in an action or proceeding in any court  or  before  any  other
    10  tribunal,   board,   agency  or  person;  provided,  however,  that  the
    11  provisions of this subdivision shall not apply to:
    12    (a) such information as the patient, or his or her guardian,  consents
    13  to be released; or
    14    (b) statistical data compiled without reference to the identity of any
    15  such patient; or
    16    (c)  such  information  as  is released by written order of a court of
    17  competent jurisdiction, issued by such court after receipt of an  appli-
    18  cation on appropriate notice and an opportunity for all relevant parties
    19  to be heard, showing good cause for the following reasons:
    20    (i) other ways of obtaining the information are not available or would
    21  be ineffective; or
    22    (ii)  there  is a reasonable likelihood that the records will disclose
    23  information of substantial value in a civil and/or criminal proceeding.
    24    In any application brought under  this  paragraph,  unless  the  court
    25  orders  all  papers filed under seal, the subject of the record shall be
    26  identified only by fictitious name, and the application  and  responding
    27  papers shall not contain or otherwise disclose the subject's identity or
    28  other confidential information.
    29    4. On or before July first, two thousand twenty-five, the commissioner
    30  shall issue a report on the administration of this program to the gover-
    31  nor,  the  temporary president of the senate, the minority leader of the
    32  senate, the speaker of the assembly, and  the  minority  leader  of  the
    33  assembly.  Such report shall contain such recommendations for additional
    34  legislation as the commissioner deems necessary.
    35    § 2. Subdivision 1 of section 207 of the public health law is  amended
    36  by adding a new paragraph (r) to read as follows:
    37    (r)  Familial  dysautonomia,  Canavan's  disease and Tay-Sachs disease
    38  education, screening, and counseling.
    39    § 3. This act shall take effect on the one hundred eightieth day after
    40  it shall have become a law. Effective immediately, the addition,  amend-
    41  ment and/or repeal of any rule or regulation necessary for the implemen-
    42  tation  of  this act on its effective date are authorized to be made and
    43  completed on or before such effective date.
Go to top